What is the catalog number for Bergapten-d3?

The catalog number for Bergapten-d3 is HY-N0370S.

What sizes are available for Bergapten-d3?

Bergapten-d3 is available in the following size(s): 1 mg, 5 mg.

How many pack sizes does Bergapten-d3 come in?

Bergapten-d3 is available in 2 different pack sizes.

Is Bergapten-d3 in stock?

Bergapten-d3 is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Bergapten-d3?

Bergapten-d3 is manufactured by QuantiMol.

What is the estimated delivery time for Bergapten-d3?

Estimated delivery time for Bergapten-d3 is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Bergapten-d3?

The safety data sheet for Bergapten-d3 is available here: http://file.medchemexpress.com/batch_PDF/HY-N0370S/.

Bergapten-d3

Bergapten-d3 is deuterium labeled Bergapten. Bergapten is a natural anti-inflammatory and anti-tumor agent. Bergapten is inhibitory towards mouse and human CYP isoforms.

Product Specifications

CAS Number

2749409-59-2

Product Name Alternative

5-Methoxypsoralen-d3

UNSPSC

12352005

Target

Autophagy; Cytochrome P450; Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Autophagy; Metabolic Enzyme/Protease; Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Solubility

10 mM in DMSO

Smiles

O=C1C=CC2=C(OC([2H])([2H])[2H])C3=C(OC=C3)C=C2O1

Molecular Formula

C12H5D3O4

Molecular Weight

219.21

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Lee YM, et al. Effects of 5-methoxypsoralen (5-MOP) on arylamine N-acetyltransferase activity in the stomach and colon of rats and human stomach and colon tumor cell lines. In Vivo. 2005 Nov-Dec;19 (6) :1061-9.|[3]Li XJ, et al. Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. Int J Mol Med. 2016 Dec;38 (6) :1661-1672.